The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.
This report contains market size and forecasts of Oral Insulin in global, including the following market information:
Global Oral Insulin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oral Insulin Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Oral Insulin companies in 2021 (%)
The global Oral Insulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Type 1 Diabetes Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Insulin include Novo Nordisk, Oramed Pharmaceuticals, vTv Therapeutics, Diabetology, Generex Biotechnology, Coromed and Nektar Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Insulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Insulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Insulin Market Segment Percentages, by Type, 2021 (%)
Type 1 Diabetes
Type 2 Diabetes
Global Oral Insulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Insulin Market Segment Percentages, by Application, 2021 (%)
Female
Male
Global Oral Insulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oral Insulin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Insulin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oral Insulin revenues share in global market, 2021 (%)
Key companies Oral Insulin sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Oral Insulin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Oramed Pharmaceuticals
vTv Therapeutics
Diabetology
Generex Biotechnology
Coromed
Nektar Therapeutics